NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT05919264 2026-05-28FOG-001 in Locally Advanced or Metastatic Solid TumorsParabilis Medicines, Inc.Phase 1/2 Recruiting595 enrolled